Related Experiment Video
Updated: Aug 10, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
[Circulating troponin I assay: uses and misuses in medical practice]
1Unité de réanimation chirurgicale, centre hospitalier de Bicêtre, Upres EA 3540, faculté de médecine Paris-Sud, 94275 Le Kremlin-Bicêtre cedex, France. alain.edouard@bct.ap-hop-paris.fr
Insights
Cardiac troponin I (cTnI) assays accurately quantify myocardial injury and diagnose cardiac complications. Elevated cTnI levels confirm acute coronary syndrome severity and circulatory failure, aiding clinical decision-making.
Area of Science:
- Biochemistry
- Cardiology
- Clinical Diagnostics
Context:
- Cardiac troponin I (cTnI) is crucial for myocardial contractile function.
- Assays for circulating cTnI are highly specific for the cardiac isoform.
- Accurate quantification of myocardial injury requires recognizing both free and combined cTnI.
Purpose:
- To highlight the diagnostic utility of cardiac troponin I (cTnI) assays.
- To emphasize cTnI's specificity in diagnosing postoperative cardiac complications.
- To explore cTnI's role in assessing acute circulatory failure and acute coronary syndrome.
Summary:
- Circulating cTnI assays are specific for cardiac injury, aiding diagnosis of postoperative complications by excluding peripheral muscle trauma.
- cTnI levels reflect the severity of acute circulatory failure from various origins (cardiac, hemorrhagic, septic).
- While confirming acute coronary syndrome severity, cTnI's predictive role for mortality and hospital admissions is limited; positive results in asymptomatic patients require further investigation for occult cardiac disease.
Impact:
- Enhances the diagnosis of cardiac complications, particularly postoperatively.
- Provides a reliable marker for the magnitude of acute circulatory failure.
- Confirms acute coronary syndrome severity and offers prognostic value, guiding patient management.
Abstract:
Cardiac troponin I (cTnI) contributes to the modulation of the myocardial contractile function in the troponins complex. The assay of circulating cTnI is highly specific of the cardiac isoform and allows a quantification of the myocardial injury provided that both free and combined cTnI were recognized by the antibodies. The assay is a major contribution to the diagnosis of postoperative cardiac complications through its specificity because peripheral muscle trauma is a confounding factor during this period. Circulating cTnI mirrors the magnitude of an acute circulatory failure whatever the origin (cardiac, hemorrhagic or septic). A positive cTnI assay in an "asymptomatic" patient has to be confirmed and needs some investigations to discard an occult cardiac disease; cTnI has a limited role by itself in predicting mortality and hospital admissions. Circulating cTnI confirms the severity of an acute coronary syndrome and has a level-dependent prognostic value.
More Related Videos
09:23Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
Related Concept Videos
Errors occurring during blood pressure monitoring
Several factors...
Heart Failure Drugs: Inotropic Agents
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies